ADVERTISEMENT
search.svg

Pharmacy News

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

Survey: One-third of consumers would ignore laws against buying from online pharmacies

According to a new survey from the Alliance for Safe Online Pharmacies (ASOP) Global Foundation, almost half of Americans gamble with their lives to buy medication from online sources—even though the overwhelming majority of them operate illegally. That’s just one of the alarming findings from the organization’s 2021 survey of American perceptions and use of online pharmacies, which was commissioned from Abacus Data.

FDA alerts health professionals about varenicline recall

After Pfizer announced in late June that it was halting worldwide distribution of varenicline (Chantix) after detecting elevated levels of nitrosamines in the drug, FDA came out to alert patients and health professionals about the voluntary recall.

FDA: Don’t use antibody testing to evaluate immunity after COVID-19 vaccination

FDA reminded health care professionals and the public that results from currently authorized COVID-19 antibody tests should not be used to assess a person’s level of immunity or protection from COVID-19 at any time, particularly after the person has received a COVID-19 vaccination.

RSS
12